Solifenacin 5 & 10 Glenmark 5 mg, 10 mg Fim-coated tablets
PDF Leaflet Revision Date: 17 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of overactive bladder syndrome.
Dosage (summary)
5 mg daily, may increase to 10 mg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Anticholinergic medicines
- Cholinergic receptor agonists
- Ketoconazole
Contraindications
- Hypersensitivity to solifenacin
- Inability to pass water
- Uncontrolled narrow angle glaucoma
- Myasthenia gravis
- Toxic megacolon
- Severe kidney disease
- Severe liver disease
- Fast, irregular heartbeats
Common side effects
- Blurred vision
- Dry mouth
- Constipation
- Nausea
- Dyspepsia
Counselling Points
- Take with or without food.
- Do not crush or chew tablets.
- Avoid driving if affected.
Serious warnings
- Risk of confusion in elderly
- Angioedema
- Potentially life-threatening allergic reactions
Important Disclaimer
The Solifenacin 5 & 10 Glenmark 5 mg, 10 mg Fim-coated tablets professional information leaflet below is the property of Glenmark Pharmaceuticals South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
